Muhammad Abdullah Ali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammad Abdullah Ali has a total of 161 co-authors. Here are the top co-authors by number of shared publications:
- Zaryab Bacha
Khyber Medical College, Peshawar, Pakistan
10 shared publications - Fazia Khattak
Department of Medicine, Khyber Medical College, Peshawar, Pakistan
8 shared publications - Abdullah Afridi
Department of Medicine, Khyber Medical College, Peshawar, Pakistan
7 shared publications - Fatima Sajjad
Department of Medicine, Khyber Medical College, Peshawar, Pakistan
7 shared publications - Raheel Ahmed
Newcastle Hospitals NHS Foundation Trust, United Kingdom; Translational and Clinical Research Institute, Newcastle University, United Kingdom
7 shared publications - Kamil Ahmad Kamil
Chief, Internal Medicine Department Nasrat Bashir Curative Hospital Kandahar Afghanistan
6 shared publications
Latest Publications
- Open Access
- 11 April 2026
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 42 (4) , 1019-1025
Evaluating the efficacy of right vertical infra-axillary thoracotomy vs. standard median sternotomy for atrial septal defect repairs: A single center analysis from Pakistan
Objective: To compare early postoperative outcomes of Right Vertical Infra-Axillary Thoracotomy (RVIAT) versus Standard Median Sternotomy (SMS) for atrial septal defect (ASD) and partial atrioventricular septal defect (AVSD) repair. Methodology: A retrospective study was conducted from June 2024 to July 2025 at the Peshawar Institute of Cardiology. Patients were divided into SMS (n=36) and RVIAT (n=36) groups. Operative times, hematologic parameters, transfusion requirements, ventilation duration, drainage volume, ICU/hospital stay, and complications were analyzed. Multivariate regression was used to adjust for age differences. Results: The SMS group was significantly older than the RVIAT group (18.39 ± 11.65 vs. 6.80 ± 5.91 years; p<0.001). SMS showed longer cross-clamp time and higher ventilation time, chest drainage, and blood transfusion requirements. After adjusting for age, RVIAT retained lower blood transfusion volume, less chest drainage, and higher preoperative hemoglobin and platelet counts. ICU stay, hospital stay, and major complications were comparable between groups, with only one re-opening and two residual shunts in SMS. Conclusions: RVIAT is a safe, minimally invasive alternative to sternotomy, offering reduced postoperative morbidity and superior cosmetic outcomes. This is particularly advantageous for pediatric and young adult patients.
- 11 April 2026
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 42 (4) , 1019-1025
Open AccessEvaluating the efficacy of right vertical infra-axillary thoracotomy vs. standard median sternotomy for atrial septal defect repairs: A single center analysis from Pakistan
Objective: To compare early postoperative outcomes of Right Vertical Infra-Axillary Thoracotomy (RVIAT) versus Standard Median Sternotomy (SMS) for atrial septal defect (ASD) and partial atrioventricular septal defect (AVSD) repair. Methodology: A retrospective study was conducted from June 2024 to July 2025 at the Peshawar Institute of Cardiology. Patients were divided into SMS (n=36) and RVIAT (n=36) groups. Operative times, hematologic parameters, transfusion requirements, ventilation duration, drainage volume, ICU/hospital stay, and complications were analyzed. Multivariate regression was used to adjust for age differences. Results: The SMS group was significantly older than the RVIAT group (18.39 ± 11.65 vs. 6.80 ± 5.91 years; p<0.001). SMS showed longer cross-clamp time and higher ventilation time, chest drainage, and blood transfusion requirements. After adjusting for age, RVIAT retained lower blood transfusion volume, less chest drainage, and higher preoperative hemoglobin and platelet counts. ICU stay, hospital stay, and major complications were comparable between groups, with only one re-opening and two residual shunts in SMS. Conclusions: RVIAT is a safe, minimally invasive alternative to sternotomy, offering reduced postoperative morbidity and superior cosmetic outcomes. This is particularly advantageous for pediatric and young adult patients.
- Open Access
- 27 March 2026
- Published by S. Karger AG in Endocrinology Insights
- p. 1-10
Cardiovascular Disease Mortality in Patients with Hypothyroidism: A 22-Year National Analysis of US Trends and Disparities
Introduction: Hypothyroidism is a prevalent endocrine disorder that has been linked to adverse cardiovascular outcomes. However, national-level trends and disparities in cardiovascular disease (CVD)-related mortality among individuals with hypothyroidism remain incompletely characterized. This study aimed to evaluate long-term temporal trends and demographic disparities in CVD mortality among US adults with hypothyroidism. Methods: We conducted a retrospective population-based analysis using death certificate data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database from 1999 to 2020. Adults aged ≥25 years with hypothyroidism were identified using ICD-10 codes E02–E03, with CVD-related deaths defined by ICD-10 codes I00–I99. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated using the 2000 US standard population. Temporal trends were analyzed using joinpoint regression to estimate annual percent change (APC), and subgroup analyses were performed by sex, race/ethnicity, age group, urban-rural status, and place of death. Results: Between 1999 and 2020, 382,906 CVD-related deaths were associated with hypothyroidism, corresponding to an overall AAMR of 8.00 per 100,000. Mortality rates increased steadily over the study period, peaking at 10.12 per 100,000 in 2020, with the most pronounced rise occurring between 2018 and 2020 (APC 14.01%). Women accounted for nearly three times as many deaths as men, although mortality rates increased more rapidly among men. Non-Hispanic white individuals exhibited the highest absolute mortality burden, while Hispanic populations experienced the fastest growth in mortality rates. The largest relative increases were observed among adults aged 35–44 and 45–54 years. Mortality rates were consistently higher in rural compared with urban areas, and the majority of deaths occurred in long-term care facilities. Conclusion: CVD-related mortality among US adults with hypothyroidism has risen substantially over the past two decades, with marked disparities across sex, age, race/ethnicity, and geographic location. These findings highlight the need for targeted cardiovascular risk assessment, early detection of hypothyroidism, and integrated management strategies, particularly in high-risk and underserved populations, to mitigate rising mortality and reduce health inequities.
- 27 March 2026
- Published by S. Karger AG in Endocrinology Insights
- p. 1-10
Open AccessCardiovascular Disease Mortality in Patients with Hypothyroidism: A 22-Year National Analysis of US Trends and Disparities
Introduction: Hypothyroidism is a prevalent endocrine disorder that has been linked to adverse cardiovascular outcomes. However, national-level trends and disparities in cardiovascular disease (CVD)-related mortality among individuals with hypothyroidism remain incompletely characterized. This study aimed to evaluate long-term temporal trends and demographic disparities in CVD mortality among US adults with hypothyroidism. Methods: We conducted a retrospective population-based analysis using death certificate data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database from 1999 to 2020. Adults aged ≥25 years with hypothyroidism were identified using ICD-10 codes E02–E03, with CVD-related deaths defined by ICD-10 codes I00–I99. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated using the 2000 US standard population. Temporal trends were analyzed using joinpoint regression to estimate annual percent change (APC), and subgroup analyses were performed by sex, race/ethnicity, age group, urban-rural status, and place of death. Results: Between 1999 and 2020, 382,906 CVD-related deaths were associated with hypothyroidism, corresponding to an overall AAMR of 8.00 per 100,000. Mortality rates increased steadily over the study period, peaking at 10.12 per 100,000 in 2020, with the most pronounced rise occurring between 2018 and 2020 (APC 14.01%). Women accounted for nearly three times as many deaths as men, although mortality rates increased more rapidly among men. Non-Hispanic white individuals exhibited the highest absolute mortality burden, while Hispanic populations experienced the fastest growth in mortality rates. The largest relative increases were observed among adults aged 35–44 and 45–54 years. Mortality rates were consistently higher in rural compared with urban areas, and the majority of deaths occurred in long-term care facilities. Conclusion: CVD-related mortality among US adults with hypothyroidism has risen substantially over the past two decades, with marked disparities across sex, age, race/ethnicity, and geographic location. These findings highlight the need for targeted cardiovascular risk assessment, early detection of hypothyroidism, and integrated management strategies, particularly in high-risk and underserved populations, to mitigate rising mortality and reduce health inequities.
- Open Access
- 9 February 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (2)
Rare Case of Anterior Sacral Meningocele in a 30‐Year‐Old Male: Surgical Excision Using the Posterior Sagittal Approach
Anterior sacral meningocele (ASM) is an uncommon congenital spinal abnormality in which the meningeal sac herniates through an abnormality in the anterior sacrum into the presacral space. It is more observed in females and usually asymptomatic; large ASMs may cause pressure effects on nearby pelvic structures. A 30‐year‐old male presented with prolonged constipation and recurrent episodes of urinary retention, which developed to complete urinary obstruction. Ultrasound demonstrated a large presacral cystic mass, and MRI confirmed the diagnosis of an ASM. Pelvic x‐ray revealed the classic Scimitar Sign. Neurological examination showed no abnormalities. The patient was subjected to surgical excision through the posterior sagittal technique. Intraoperative steps consisted of laminectomy, durotomy, sac decompression, and fascial graft repairing. After the procedure, the patient experienced a smooth recovery with notable improvement in bowel and urinary symptoms. ASM is an uncommon etiology of pelvic mass and neurogenic bladder symptoms occurring in adults. This case underscores the diagnostic importance of MRI and pelvic X‐ray, and also supports the posterior sagittal approach as an effective, low‐complication surgical approach. ASM should be taken as a differential diagnosis for adult patients having symptoms of chronic constipation and urinary retention. Prompt imaging and surgical treatment can notably improve outcomes.
- 9 February 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (2)
Open AccessRare Case of Anterior Sacral Meningocele in a 30‐Year‐Old Male: Surgical Excision Using the Posterior Sagittal Approach
Anterior sacral meningocele (ASM) is an uncommon congenital spinal abnormality in which the meningeal sac herniates through an abnormality in the anterior sacrum into the presacral space. It is more observed in females and usually asymptomatic; large ASMs may cause pressure effects on nearby pelvic structures. A 30‐year‐old male presented with prolonged constipation and recurrent episodes of urinary retention, which developed to complete urinary obstruction. Ultrasound demonstrated a large presacral cystic mass, and MRI confirmed the diagnosis of an ASM. Pelvic x‐ray revealed the classic Scimitar Sign. Neurological examination showed no abnormalities. The patient was subjected to surgical excision through the posterior sagittal technique. Intraoperative steps consisted of laminectomy, durotomy, sac decompression, and fascial graft repairing. After the procedure, the patient experienced a smooth recovery with notable improvement in bowel and urinary symptoms. ASM is an uncommon etiology of pelvic mass and neurogenic bladder symptoms occurring in adults. This case underscores the diagnostic importance of MRI and pelvic X‐ray, and also supports the posterior sagittal approach as an effective, low‐complication surgical approach. ASM should be taken as a differential diagnosis for adult patients having symptoms of chronic constipation and urinary retention. Prompt imaging and surgical treatment can notably improve outcomes.
- Open Access
- 20 January 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 1849-1860
Intensive versus standard blood pressure management after endovascular therapy in acute ischemic stroke: a systematic review and meta-analysis
Endovascular thrombectomy (EVT) has improved the therapy of acute ischemic stroke, patients still have functional impairments after reperfusion. This updated meta-analysis assesses whether intense blood pressure (BP) management following successful EVT enhances results and reduces problems associated with reperfusion. PubMed, Embase, and Cochrane databases were systematically searched using relevant keywords from inception until July 2025. A total of five studies were included after final screening. Outcomes were reported as excellent clinical outcomes, functional independence, all-cause mortality at 90 days, any intracranial hemorrhage within 24 h, etc. Interstudy heterogeneity was assessed using I 2 and X 2 statistics ( I 2 > 50% = significant heterogeneity). Statistical calculations used Review Manager 5.4.1, with a P -value of P = 0.03) and functional independence (mRS modified Rankin Scale 0–2) was both markedly enhanced by intensive BP control (RR = 0.82; 95% CI: 0.74–0.91; P = 0.0002). It did not, however, have a significant effect on all-cause death at 90 days, symptomatic or any cerebral bleeding, stroke recurrence, or excellent clinical outcomes (mRS 0–1). A significant correlation was seen between a greater incidence of hypotensive episodes and severe BP lowering (RR = 1.77; P < 0.00001). It also raises the risk of hypotension without reducing the danger of hemorrhage or death. Following EVT, intense BP control may enhance early neurological results and functional independence, but it also raises the risk of hypotension without reducing death or hemorrhage.
- 20 January 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 1849-1860
Open AccessIntensive versus standard blood pressure management after endovascular therapy in acute ischemic stroke: a systematic review and meta-analysis
Endovascular thrombectomy (EVT) has improved the therapy of acute ischemic stroke, patients still have functional impairments after reperfusion. This updated meta-analysis assesses whether intense blood pressure (BP) management following successful EVT enhances results and reduces problems associated with reperfusion. PubMed, Embase, and Cochrane databases were systematically searched using relevant keywords from inception until July 2025. A total of five studies were included after final screening. Outcomes were reported as excellent clinical outcomes, functional independence, all-cause mortality at 90 days, any intracranial hemorrhage within 24 h, etc. Interstudy heterogeneity was assessed using I 2 and X 2 statistics ( I 2 > 50% = significant heterogeneity). Statistical calculations used Review Manager 5.4.1, with a P -value of P = 0.03) and functional independence (mRS modified Rankin Scale 0–2) was both markedly enhanced by intensive BP control (RR = 0.82; 95% CI: 0.74–0.91; P = 0.0002). It did not, however, have a significant effect on all-cause death at 90 days, symptomatic or any cerebral bleeding, stroke recurrence, or excellent clinical outcomes (mRS 0–1). A significant correlation was seen between a greater incidence of hypotensive episodes and severe BP lowering (RR = 1.77; P < 0.00001). It also raises the risk of hypotension without reducing the danger of hemorrhage or death. Following EVT, intense BP control may enhance early neurological results and functional independence, but it also raises the risk of hypotension without reducing death or hemorrhage.
- 14 January 2026
- Published by Wolters Kluwer Health in Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine
- Vol. 25 (2) , e0415
Sirolimus-Coated Versus Paclitaxel-Coated Balloons for Coronary Artery Disease: A Grade Assessed Systematic Review and Meta-Analysis
Despite advances in percutaneous coronary procedures, in-stent restenosis remains a significant challenge. Although sirolimus- and paclitaxel-coated balloons are promising alternatives, their comparative safety and efficacy remain uncertain. PubMed, Embase, and Cochrane databases were searched using relevant keywords from inception until August 2025. A total of 11 studies (7 randomized controlled trials and 4 observational cohort studies) were included, comprising 3633 participants overall. The primary outcomes assessed were target lesion revascularization and target lesion failure. Meanwhile, the Secondary outcomes included stent thrombosis, all-cause mortality, myocardial infarction, major adverse cardiovascular events, survival, binary restenosis, and angiographic endpoints (acute gain, diameter stenosis, in-segment late lumen loss, in-lesion late lumen loss, and in-segment minimal lumen diameter). Interstudy heterogeneity was assessed using I ² and X ² statistics ( I ²>50% = significant heterogeneity). Interstudy heterogeneity was low for most outcomes, including all primary clinical endpoints, with moderate heterogeneity observed only for select angiographic measures (notably in-segment late lumen loss and diameter stenosis). Statistical analysis was conducted using R software and RStudio (version 4.4.2), with a P value of < 0.05 indicating statistical significance. This meta-analysis examined studies that compared paclitaxel-coated balloon (PCB) versus standard balloon [sirolimus-coated balloon (SCB)] angioplasty. Regarding primary outcomes, there were no notable variations in target lesion failure [risk ratio (RR), 1.08, 95% CI, 0.90–1.29, P = 0.36] or target lesion revascularization (RR, 1.16, 95% CI, 0.98–1.37, P = 0.08). With all aggregated estimates being nonsignificant, secondary outcomes such as stent thrombosis, all-cause mortality, myocardial infarction, major adverse cardiovascular events, and survival were similar between groups. Angiographic endpoints revealed no discernible variations in late lumen loss (in-lesion and in-segment), acute gain, or diameter stenosis. Nonetheless, the SCB group’s minimal lumen diameter was significantly smaller than that of the PCB group (MD, −0.08 mm, 95% CI, −0.14 to −0.01, P = 0.02). In treating coronary in-stent restenosis, SCB and PCBs show similar overall safety and effectiveness; lesion-specific angiographic variations indicate that customized selection may improve patient outcomes.
- 14 January 2026
- Published by Wolters Kluwer Health in Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine
- Vol. 25 (2) , e0415
Sirolimus-Coated Versus Paclitaxel-Coated Balloons for Coronary Artery Disease: A Grade Assessed Systematic Review and Meta-Analysis
Despite advances in percutaneous coronary procedures, in-stent restenosis remains a significant challenge. Although sirolimus- and paclitaxel-coated balloons are promising alternatives, their comparative safety and efficacy remain uncertain. PubMed, Embase, and Cochrane databases were searched using relevant keywords from inception until August 2025. A total of 11 studies (7 randomized controlled trials and 4 observational cohort studies) were included, comprising 3633 participants overall. The primary outcomes assessed were target lesion revascularization and target lesion failure. Meanwhile, the Secondary outcomes included stent thrombosis, all-cause mortality, myocardial infarction, major adverse cardiovascular events, survival, binary restenosis, and angiographic endpoints (acute gain, diameter stenosis, in-segment late lumen loss, in-lesion late lumen loss, and in-segment minimal lumen diameter). Interstudy heterogeneity was assessed using I ² and X ² statistics ( I ²>50% = significant heterogeneity). Interstudy heterogeneity was low for most outcomes, including all primary clinical endpoints, with moderate heterogeneity observed only for select angiographic measures (notably in-segment late lumen loss and diameter stenosis). Statistical analysis was conducted using R software and RStudio (version 4.4.2), with a P value of < 0.05 indicating statistical significance. This meta-analysis examined studies that compared paclitaxel-coated balloon (PCB) versus standard balloon [sirolimus-coated balloon (SCB)] angioplasty. Regarding primary outcomes, there were no notable variations in target lesion failure [risk ratio (RR), 1.08, 95% CI, 0.90–1.29, P = 0.36] or target lesion revascularization (RR, 1.16, 95% CI, 0.98–1.37, P = 0.08). With all aggregated estimates being nonsignificant, secondary outcomes such as stent thrombosis, all-cause mortality, myocardial infarction, major adverse cardiovascular events, and survival were similar between groups. Angiographic endpoints revealed no discernible variations in late lumen loss (in-lesion and in-segment), acute gain, or diameter stenosis. Nonetheless, the SCB group’s minimal lumen diameter was significantly smaller than that of the PCB group (MD, −0.08 mm, 95% CI, −0.14 to −0.01, P = 0.02). In treating coronary in-stent restenosis, SCB and PCBs show similar overall safety and effectiveness; lesion-specific angiographic variations indicate that customized selection may improve patient outcomes.
- 7 January 2026
- Published by Springer Nature in Child's Nervous System
- Vol. 42 (1) , 14
Umbilical cerebrospinal fluid fistula following ventriculoperitoneal shunt placement: a case report and literature review
Umbilical cerebrospinal fluid fistula is a rare complication associated with ventriculoperitoneal (VP) shunt. A 5-year-old girl with a history of myelomeni
- 7 January 2026
- Published by Springer Nature in Child's Nervous System
- Vol. 42 (1) , 14
Umbilical cerebrospinal fluid fistula following ventriculoperitoneal shunt placement: a case report and literature review
Umbilical cerebrospinal fluid fistula is a rare complication associated with ventriculoperitoneal (VP) shunt. A 5-year-old girl with a history of myelomeni
- 20 December 2025
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 428
Therapeutic comparison of hypertonic saline and mannitol in pediatric intracranial hypertension: a systematic review and meta-analysis
Background Elevated intracranial pressure (ICP) in pediatric patients is a critical condition that can lead to severe complications if not managed promptly. Hypertonic saline and mannitol are both commonly used to reduce ICP, yet their comparative effectiveness remains uncertain. Despite widespread use, existing studies show mixed results, with variations in treatment protocols and patient outcomes. This uncertainty underscores the need for a clearer understanding of the most effective treatment for pediatric ICP management. Aim To compare the effectiveness of hypertonic saline and mannitol in the management of elevated intracranial pressure in pediatric patients. Methods A systematic review and meta-analysis, based on the preferred reporting items for systematic reviews and meta-analysis statements, was conducted (PROSPERO: CRD420251037689). A literature review was performed (sources: PubMed, Embase, and Cochrane Library databases; end-of-search date: April 15, 2025), and quality assessment was performed using the ROB2 and NewCastle Ottawa Scale. A random-effects model was used to pool the data for the meta-analyses. Results A total of 631 patients from five studies were included in the mortality analysis, with 367 in the HTS group and 264 in the mannitol group. The risk of mortality was not significantly different between groups (RR, 0.91; 95% CI, 0.54, 1.52; p = 0.71), with moderate heterogeneity observed (I2 = 41%). Two studies assessing ICP change at 72 h found no significant difference (mean difference: −3.79 mmHg, p = 0.46). Similarly, no significant difference was found for CPP change (mean difference: 4.55 mmHg, p = 0.36). Secondary outcomes, including ICU and hospital length of stay and mechanical ventilation duration, showed no significant differences between groups. Conclusions This meta-analysis found no significant differences in mortality, ICP, or CPP changes between the HTS and mannitol groups. Secondary outcomes, including ICU and hospital length of stay and mechanical ventilation duration, also showed no notable differences. These findings suggest that both hypertonic saline and mannitol may be similarly effective for managing elevated ICP in pediatric patients.
- 20 December 2025
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 428
Therapeutic comparison of hypertonic saline and mannitol in pediatric intracranial hypertension: a systematic review and meta-analysis
Background Elevated intracranial pressure (ICP) in pediatric patients is a critical condition that can lead to severe complications if not managed promptly. Hypertonic saline and mannitol are both commonly used to reduce ICP, yet their comparative effectiveness remains uncertain. Despite widespread use, existing studies show mixed results, with variations in treatment protocols and patient outcomes. This uncertainty underscores the need for a clearer understanding of the most effective treatment for pediatric ICP management. Aim To compare the effectiveness of hypertonic saline and mannitol in the management of elevated intracranial pressure in pediatric patients. Methods A systematic review and meta-analysis, based on the preferred reporting items for systematic reviews and meta-analysis statements, was conducted (PROSPERO: CRD420251037689). A literature review was performed (sources: PubMed, Embase, and Cochrane Library databases; end-of-search date: April 15, 2025), and quality assessment was performed using the ROB2 and NewCastle Ottawa Scale. A random-effects model was used to pool the data for the meta-analyses. Results A total of 631 patients from five studies were included in the mortality analysis, with 367 in the HTS group and 264 in the mannitol group. The risk of mortality was not significantly different between groups (RR, 0.91; 95% CI, 0.54, 1.52; p = 0.71), with moderate heterogeneity observed (I2 = 41%). Two studies assessing ICP change at 72 h found no significant difference (mean difference: −3.79 mmHg, p = 0.46). Similarly, no significant difference was found for CPP change (mean difference: 4.55 mmHg, p = 0.36). Secondary outcomes, including ICU and hospital length of stay and mechanical ventilation duration, showed no significant differences between groups. Conclusions This meta-analysis found no significant differences in mortality, ICP, or CPP changes between the HTS and mannitol groups. Secondary outcomes, including ICU and hospital length of stay and mechanical ventilation duration, also showed no notable differences. These findings suggest that both hypertonic saline and mannitol may be similarly effective for managing elevated ICP in pediatric patients.
- Open Access
- 18 November 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (1) , 959-960
Nipah virus outbreak in Bangladesh: an enduring zoonotic threat
- 18 November 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (1) , 959-960
Open AccessNipah virus outbreak in Bangladesh: an enduring zoonotic threat
- Open Access
- 13 November 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (12) , 8699-8707
Safety and efficacy of darolutamide in combination with androgen-deprivation therapy for prostate cancer: a systematic review and meta-analysis
Background: Prostate cancer is the second most common cancer in men. Androgen deprivation therapy (ADT) is the standard treatment, but many patients develop resistance, leading to metastatic castration-resistant prostate cancer (CRPC). Darolutamide, an androgen receptor inhibitor, has shown promise in treating prostate cancer, but its combination with ADT remains under-researched. This study evaluated the safety and efficacy of darolutamide with ADT in patients with hormone-sensitive prostate cancer and CRPC compared to ADT plus placebo. Methods: We searched electronic databases for randomized controlled trials on darolutamide + ADT in prostate cancer. The primary outcome was overall survival, and secondary outcomes included pain progression, time to subsequent antineoplastic therapy, and adverse events (fatigue, bone fractures, falls, mental disorders, rash, hypertension, and serious events). Results: Four studies ( N = 3,473) were included. Darolutamide + ADT showed no significant difference in overall survival (HR = 0.71, P = 0.28), but CRPC patients had improved survival (HR = 1.08, P = 0.007). The combination reduced pain progression [risk ratio (RR) = 0.81, P = 0.001] and delayed subsequent therapy (RR = 0.46, P < 0.00001). Risks of bone fractures (RR = 1.52, P = 0.008) and hypertension (RR = 1.28, P = 0.03) were increased. Other adverse events, such as fatigue, rash, mental disorders, falls, and serious adverse events, showed no significant differences compared to ADT plus placebo. Conclusion: Darolutamide + ADT improves outcomes for PC patients but presents safety concerns, including bone fractures and hypertension. Further trials are needed for optimal patient selection and long-term management.
- 13 November 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (12) , 8699-8707
Open AccessSafety and efficacy of darolutamide in combination with androgen-deprivation therapy for prostate cancer: a systematic review and meta-analysis
Background: Prostate cancer is the second most common cancer in men. Androgen deprivation therapy (ADT) is the standard treatment, but many patients develop resistance, leading to metastatic castration-resistant prostate cancer (CRPC). Darolutamide, an androgen receptor inhibitor, has shown promise in treating prostate cancer, but its combination with ADT remains under-researched. This study evaluated the safety and efficacy of darolutamide with ADT in patients with hormone-sensitive prostate cancer and CRPC compared to ADT plus placebo. Methods: We searched electronic databases for randomized controlled trials on darolutamide + ADT in prostate cancer. The primary outcome was overall survival, and secondary outcomes included pain progression, time to subsequent antineoplastic therapy, and adverse events (fatigue, bone fractures, falls, mental disorders, rash, hypertension, and serious events). Results: Four studies ( N = 3,473) were included. Darolutamide + ADT showed no significant difference in overall survival (HR = 0.71, P = 0.28), but CRPC patients had improved survival (HR = 1.08, P = 0.007). The combination reduced pain progression [risk ratio (RR) = 0.81, P = 0.001] and delayed subsequent therapy (RR = 0.46, P < 0.00001). Risks of bone fractures (RR = 1.52, P = 0.008) and hypertension (RR = 1.28, P = 0.03) were increased. Other adverse events, such as fatigue, rash, mental disorders, falls, and serious adverse events, showed no significant differences compared to ADT plus placebo. Conclusion: Darolutamide + ADT improves outcomes for PC patients but presents safety concerns, including bone fractures and hypertension. Further trials are needed for optimal patient selection and long-term management.
- 15 October 2025
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 23 (4) , 1-18
Hyperthermic Intraperitoneal Chemotherapy + Surgery Versus Surgery Alone for Ovarian Cancer, a Systematic Review and Meta Analysis of RCTs
- 15 October 2025
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 23 (4) , 1-18
Hyperthermic Intraperitoneal Chemotherapy + Surgery Versus Surgery Alone for Ovarian Cancer, a Systematic Review and Meta Analysis of RCTs